The Company is seeking an experienced and talented industry drug discovery and development leader to drive the execution of R&D strategy to further extend the value, impact, and opportunity of the Company’s science, its assets and collaborations, and its platform technology. The selected candidate will report into the Chief Science & Technology Officer.
This leader will have a strong scientific foundation and a demonstrated track record of producing results in cancer biology and oncology drug discovery. This individual will be an energetic and experienced scientist who will utilize his/her hands-on experience in biologics (monoclonal antibodies) drug discovery to guide the Company’s internal and collaborative preclinical/development programs. The candidate will be expected to execute on strategic research initiatives, to support novel therapeutic approaches and their clinical advancement for the treatment of cancer. The selected candidate will be expected to assist the CSTO in R&D operations, including maintaining research budgets, and internal/external research project management. He/she is also expected to keep current with relevant literature to ideate, propose, and execute on strategic preclinical research and is expected to work within a matrix organization to support internal and external research innovation aligned with clinical, legal IP, and business teams.